Michael Fu
Rutgers, The State University of New Jersey(US)University of Missouri–Kansas City(US)
Publications by Year
Research Areas
Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Viral Infections and Immunology Research, Monoclonal and Polyclonal Antibodies Research, Cardiac pacing and defibrillation studies
Most-Cited Works
- → Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases(2013)3,335 cited
- → How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)(2019)1,712 cited
- → SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe(2021)1,513 cited
- → Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity(2023)1,273 cited
- → The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial(2022)836 cited
- → Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure